STUDresearch · Non-peptide
GlyNAC
Also known as
Glycine + NAC · glycine N-acetylcysteine
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Systemic oral GSH precursor combination.
One first-night report described poor sleep; replies disagreed about whether evening NAC, glycine or individual response explained it.
The user reported dizziness/lightheadedness over three days and persistence after lowering the combined product to 300 mg, plus slightly better sleep. The post did not state per-component contents.
One user described settling on these amounts for about two years, with taurine, creatine, heavy exercise and one-meal-a-day eating as major confounders; a three-month pause made benefit seem plausible to that author.
Small 16-week older-adult trial, with a younger comparison group exposed for two weeks; weight-based study exposure is not a personal-use target.
Two-week randomized trial; the overall primary glutathione endpoint was not improved, with favorable interpretation relying on a post-hoc lower-baseline subset.
Half-life & effect duration
- Half-life in the body
- Glycine · oral community estimateAbout 1–4 hours
- NAC · total oral study estimateAbout 6.3 hours
- NAC · other oral tablet studyAbout 15–19 hours
- Felt duration people report
- Sleep reportsFirst-night poor sleep in one account; slightly better sleep in another
- Other experiencesDizziness, digestive effects or uncertain long-term benefit
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
A single GlyNAC parent half-life is not applicable because the intervention contains two precursors and targets downstream glutathione biology.
Reviewed trials specify repeated glycine and NAC exposure and outcome windows, not one intact combination analyte with a shared terminal half-life.
Component kinetics, downstream glutathione pools and clinical outcomes are different endpoints; study duration and dose frequency are not clearance estimates.
- GlyNAC supplementation in older adults — randomized clinical trial (opens in a new tab)Methods and participant sections: 24 older adults and 12 younger controls; 100 mg/kg/day glycine plus 100 mg/kg/day NAC, 16 weeks in older participants and two weeks in younger participants, with outcome and washout measurements.Small single-center older-adult study with a much shorter younger exposure and multiple outcomes; weight-based research dosing does not establish a shared combination half-life or universal response.
- Two-week randomized dose-response trial of GlyNAC in older adults (opens in a new tab)PubMed abstract: 114 older adults randomized to placebo or 2.4, 4.8 or 7.2 g/day total GlyNAC in a 1:1 ratio for two weeks; primary overall glutathione endpoint not improved, with post-hoc findings in a lower-baseline subgroup.Short trial; post-hoc subgroup inference should not replace the non-significant overall primary result. Authors disclosed company affiliations and conflicts.
Felt duration people report
Community accounts conflict on sleep and benefit, while early dizziness and GI tolerance can occur.
One 3 g plus 3 g bedtime report described first-night poor sleep. Another 600 mg GlyNAC account described dizziness/lightheadedness and slightly better sleep, then lowering the combined product to 300 mg (one capsule). Long-term users reported uncertain benefit with major lifestyle and supplement confounding.
Different amounts, timing, brands, co-supplements and goals; no blinded rechallenge or reliable per-dose duration.
- Glycine + NAC experience reports — bedtime sleep discussion (opens in a new tab)Original post reports 3 g glycine plus 3 g NAC at bedtime and poor sleep on the first night; replies conflict on whether nighttime NAC disrupts sleep and whether glycine helps it.One-night self-report, no control or rechallenge, combined components, and differing responder claims in replies.
- Strange side effects from GlyNAC — short tolerance report (opens in a new tab)Original post: 600 mg GlyNAC for three days, then 300 mg (one capsule), with dizziness/lightheadedness persisting and slightly better sleep also reported; the post did not state per-component contents.Short uncontrolled account with no product verification, medical evaluation, separation of the two components or later same-author outcome.
- Starting GlyNAC 1:1 — long-term same-author follow-up (opens in a new tab)Complete thread and same-author later replies: eventual 6 g glycine plus 4 g NAC daily with 2 g taurine and creatine, about two years continuous use, uncertain subjective benefit, and a three-month pause/restart impression; heavy exercise and one-meal-a-day eating disclosed.Single long uncontrolled account with changing amounts and substantial supplement, diet and exercise confounding; pause/restart was not blinded.
- Glycine NAC trial — high-dose community discussion (opens in a new tab)Complete post and visible replies: one participant described 8 g/day of each with multiple other supplements and uncertain attribution; another described severe GI effects above 2 g NAC at once.Different users, amounts and co-supplements; informal language and no medical adjudication, product testing or standardized outcomes.
What people say
- Healthspan narrative: GlyNAC is discussed for aging markers, energy, or recovery more than acute gym pumps. forum
- Slow endpoints: Users often run months, not days, before claiming anything — and still confabulate. anecdote
- Stack noise: Frequently combined with multi-agent longevity stacks that destroy attribution. forum
- Biomarker talk: Some chase labs (glucose, lipids, CRP); many chase vibes. forum
- Glutathione / aging trials: Human studies (e.g. older adult GlyNAC work) report metabolic and glutathione markers improvements in some papers. trial
Doses people talk about
- Lower inherited community band: 600 mg–1.2 g of each daily is preserved from the legacy record, not a starting dose or titration recommendation. A separate inspected post described 600 mg GlyNAC, later 300 mg (one capsule), without stating per-component contents. forum
- Mid DIY band: many longevity threads land around 3–5 g glycine + 1.2–2.5 g NAC per day before chasing full study grams. forum
- Framing: Glycine + NAC combo (GlyNAC) — human longevity studies + DIY supplement culture. trialforum
- Fixed lower study arms: some trials used fixed actives like ~1.2 g NAC + ~1.2 g glycine daily. trial
- Published older-adult style band: about 100 mg/kg/day glycine + 100 mg/kg/day NAC (example: ~7 g glycine + ~7 g NAC for a 70 kg adult), often split 2×/day. trial
How it may feel
- Days 1–7: Oral GI effects, dizziness, or sleep changes can dominate before any claimed benefit. Reports conflict: one 3 g + 3 g bedtime trial disrupted sleep, while another 600 mg GlyNAC account reported lightheadedness and slightly better sleep. forum
- Day 1: Oral logistics and tolerance are more noticeable than a “miracle” effect. One 3 g glycine + 3 g NAC bedtime report described poor sleep on the first night; replies disagreed on whether glycine or evening NAC was responsible. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
- Weeks–months: Trial blocks often multi-week to months. trial
Cycles people discuss
- Community duration: Accounts include short tolerance checks, continuous multi-year use, and pause/restart experiments. The on/off pattern is mixed and attribution is often confounded, not an established cycle. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Continuous study arms: Common. trial
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Precursor logic: NAC/glycine support GSH synthesis rather than a peptide half-life story. trial
- Published PK: Where human PK exists it should override forum half-life memes for GlyNAC. trial
More on what it is
- Not a single molecule brand requirement: Two common supplements co-taken. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for GlyNAC, not proof it works for you. forum
- What it is: Glycine + N-acetylcysteine combination studied for glutathione and aging-related outcomes. trial
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- With exercise / sleep hygiene: Confounded lifestyle. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- GI from NAC: Nausea/reflux possible. forum
- Sulfur burps: Classic NAC. forum
- Dizziness / lightheadedness: One user reported both after 600 mg GlyNAC and again after lowering it to 300 mg (one capsule); the post did not state per-component contents, and the same short account also mentioned slightly better sleep. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
